Skip to main content
Equibles

Trexquant Investment LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1633445 STAMFORD, CT
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,935,356
-$2,316,801 QoQ
Shares Held
116,022
-50.8% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#98
of 354 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. ACAD ranks #58 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 505,160 $35,376,354
2 TWST
Twist Bioscience Corp
 255,271 $26,262,280
3 REGN
Regeneron Pharmaceuticals, Inc.
 41,839 $26,088,290
4 RVMD
Revolution Medicines, Inc.
 120,122 $22,496,448
5 AXSM
Axsome Therapeutics, Inc.
 83,679 $20,482,108
6 RARE
Ultragenyx Pharmaceutical Inc.
 556,385 $18,577,695
7 INSM
INSMED Inc
 156,553 $16,691,680
8 SRRK
Scholar Rock Holding Corp
 275,712 $15,164,160

All Filings in ACAD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,935,356 116,022
2026-03-31 $5,252,157 235,946
2025-12-31 $7,954,291 297,802
2025-09-30 $4,867,397 228,088
2025-06-30 $10,999,599 509,949
2025-03-31 $4,888,273 294,297
2024-12-31 $7,948,394 433,155
2024-09-30 $5,905,750 383,989
2024-06-30 $4,902,267 301,678
2024-03-31 $6,277,558 339,511
2023-12-31 $1,319,528 42,144
2023-06-30 $3,762,161 157,084
2023-03-31 $2,055,087 109,197
2022-12-31 $1,604,544 100,788
2022-09-30 $778,408 47,580
2022-03-31 $2,388,382 98,612
2021-09-30 $397,012 23,902
2021-06-30 $966,673 39,634
2020-12-31 $1,272,187 23,797
2020-09-30 $752,606 18,245
2020-06-30 $735,192 15,168
2020-03-31 $747,656 17,696